The global microelectronic medical implants market size is predicted to value USD 57.12 billion by 2025. The market is subject to witness substantial growth in upcoming years due to the rising occurrence of diseases like epilepsy, cardiac disorders, and Parkinson’s disease. Factors responsible for market growth are an increase in the geriatric population, a large number of administrative approvals for the use of the latest advanced electronic devices in the healthcare sector, and the advent of advanced technologies for healthcare. The microelectronic medical implants market is expected to grow at a CAGR of 9.8% in the years to come.
The rising occurrence of cardiac disorders is mainly responsible for the high-end demand for microelectronic medical implants. Some of the cardiovascular disorders like cardiac arrest, heart failure, strokes, and ischemic heart disease (IHD) use microelectronic medical implants like pacemakers and defibrillators. Cardiovascular diseases (CVDs) and coronary heart disease are major causes of death in various regions of the globe, the critical importance of microelectronic medical implants to treat these diseases is substantially rising. Such key factors are spurring the growth of the microelectronic medical implants market in the forecast period.
Implantable medical devices are used for treating a wide range of health conditions. The typical use of microelectronic medical implants occurs in monitoring as well as diagnostic purposes. Since last decades, the development of microelectronic medical implants witnessed remarkable progress with an immense advancement in microelectronics & nano-electronics, electrode technology, and signal processing methodologies. The modern-day technology implemented in implantable medical devices offers wireless communication and charging.
The successful implementation of implantable medical devices consists of numerous problems faced during its operations. These problems are associated with viability, bidirectional data communication speeds, power supply, and lower noise ratio. Other challenges faced during its operation are less efficient power delivery for the recording, and less safe stimulation techniques to prevent nerve damage and electrode damage. The major emphasis is on neural recording and stimulation techniques that are appropriate for fabrication methods in advanced silicon processes and biotelemetry methods, implemented for power and data transfer, alongside a substantial focus on techniques deployed for radio inductive coupling.
Numerous applications are associated with the use of microelectronics medical implants similar to orthopedics, pacemakers, CVD stents, implantable cardioverter-defibrillator (ICD), neuro-prosthetics, and drug delivery systems. Subsequently, a longer life span in humans for the current scenarios has led to increasingly occurring age-related disorders. Due to which the requirement for the latest treatments methodologies, medical implants, neuro-prostheses, and longer pharmaceutical usage has seen major growth over the past few years. Joint diseases treatment is a prime example of the varying demands for medical treatment with the use of advanced electronic devices.
A major emphasis for creating the next generation of pacing devices to minimize mortality and enhance treatment outcomes has led to higher costing flexibility in a growing cost-efficient healthcare sector. It is expected that devices belonging to microelectronic medical implants such as cardiovascular stents are witnessing a similar growth rate as per the pacing devices.
Though, substantial demand for structural implants due to technological advancement in heart valves, ventricular assist devices, and display monitors, is attributed to the rising preference by healthcare professionals in recent years. An orthopedic implant is the largest consumable device segment in the supply chain. Progress of microelectronic medical implants market in near future is also associated with the increasing incidences of degenerative musculoskeletal diseases and varying lifestyle due to sports and exercise injuries.
The microelectronic medical implants Industry is divided into regional market segments such as North America, Europe, Asia-Pacific, Latin America, and Africa. North America has shown major growth in recent years owing to encouraging government reforms, rising approvals from several government agencies, and increasing occurrence of cardiac diseases.
Asia-Pacific’s market is predicted to hold a higher share in the microelectronic medical implant market with massive growth in the forecast period. Countries such as India, China, and Singapore are leading the Asia-Pacific market with growing healthcare facilities and generating substantial investment by multinational market players due to potential opportunities in the region. The key players in the microelectronic medical implants Industry are Zimmer Biomet Holdings, Incorporations, Cochlear Co., Ltd., Medtronic plc, Abbott Laboratories, Boston Scientific Co., and Philips N.V.
Market Segment:
Microelectronic Medical Implants Product Outlook (Revenue, USD Million, 2014 - 2025)
• Pacemakers & Defibrillators
• Neurostimulators
• Implantable Drug Pumps
• Spinal Fusion Stimulators
• Cochlear Implants
• Ocular Implants
• Others
Microelectronic Medical Implants Technology Outlook (Revenue, USD Million, 2014 - 2025)
• RF Technology
• Sensors
• Other Technology
Microelectronic Medical Implants Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• the U.S.
• Canada
• Europe
• Germany
• the U.K.
• the Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• the Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
Research Support Specialist, USA